General Updates

September 15, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Sub: Communication sent to physical shareholders to furnish PAN and KYC details Ref: SEBI/HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026, and SEBI Circular bearing reference no. SEBI/HO/MIRSD/MIRSD-POD-1/P/CIR/2024/81 dated June 10, 2024 Dear Sir / Madam, In compliance with the aforesaid SEBI Circulars, please note that reminder letters dated September 15, 2026, is being sent to the shareholders holding shares in physical mode, requesting them to furnish PAN and KYC details for updation, to the Company / Registrar & Transfer Agent of the Company i.e. Skyline Financial Services Private Limited along with request to dematerialize the shares with Depository Participant. A copy of the reminder letter is enclosed herewith for your reference. The forms prescribed as per the aforesaid Circulars for updation of various details of the shareholders is made available on the website of the Company at https://www.panaceabiotec.com/en/investor-links/other-important-information and on the website of Skyline Financial Services Private Limited, the Registrar and Share Transfer Agent of the Company at https://www.skylinerta.com/pages/service-requests-kyc-forms.php. This is for your kind information and record please. Thanking you, Sincerely yours, for Panacea Biotec Limited Ankit Jain General Manager - Legal & Company Secretary Encl.: As Above Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com Shareholder’s Communication September 15, 2026 Sub: Reminder Letter for mandatory registration / updation of KYC details by holders of physical securities Ref: 1. SEBI/HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026, and SEBI Circular bearing reference no. SEBI/HO/MIRSD/MIRSD-POD-1/P/CIR/2024/81 dated June 10, 2024. 2. Our earlier letters dated 25.01.2023, 11.05.2023, 12.09.2024 and 19.09.2025. Dear Shareholder, We refer to the above Circulars / Master Circular issued by Securities and Exchange Board of India (“SEBI”) that mandates all the listed companies to record PAN, Address with PIN code, Mobile Number, Bank Account details, and Specimen signatures of physical shareholders. Updation of Email ID and Nomination details by the physical shareholders has been made optional by SEBI. However, the security holders are requested to register their Email ID to avail online service and nomination details for ensuring smooth transmission of securities as well. This is applicable for all security holders holding shares in Physical Mode. The salient features and requirements of the SEBI Circulars are as follows: 1. In case of non-updation of PAN, Contact Details including Mobile Number, Bank Account details and specimen signature in respect of physical folios, dividend / interest etc. shall be paid only through electronic mode with effect from 01st April 2024 upon furnishing all the aforesaid details in entirety. Accordingly, if a security holder updates the PAN, contact details including mobile number, bank account details and specimen signature after 1st April, 2024, then any dividends / interest etc. declared by the Company during the period (i.e. from 1st April, 2024 till updation of KYC by Shareholders) pertaining to the securities of the Company and due for payment to physical shareholder, would be paid electronically only upon complying with the above requirements. Further, the physical shareholders will not be able to lodge a grievance or avail any service request from the Skyline Financial Services Pvt. Ltd. (“RTA”) till the said details are updated / provided against their folio. 2. All existing shareholders are encouraged, in their own interest, to provide ‘choice of nomination’ for ensuring smooth transmission of securities held by them as well as to prevent accumulation of unclaimed assets in securities market. In this connection, the current status of the below mentioned folio is provided for your ready reference and we request you to comply with the required mandatory fields on top priority. Name of the PAN Specimen Contact details Bank details Nominee Email Id security (mandatory) Signature including mobile (mandatory) details (optional) holder (mandatory) no. (mandatory) (optional) It is therefore, once again requested to submit the following details in the enclosed formats (wherever applicable) along with the self-attested copies of supporting documents to the RTA or the Company immediately: Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com Form Description Documents required ISR-1 Request for registering PAN, KYC Duly filled & signed Form ISR-1 along with: & Bank details or updation thereof 1. Self-attested copy of PAN card & Address (postal address, Mobile No. & (Preferably Aadhar) of the shareholder/s as per E-Mail Id) Form ISR-1. Note: PAN linked with Aadhar would only be accepted 2. Original cancelled cheque leaf with printed name of the registered shareholder or provide legible copy of Bank passbook or Bank statements attested by the bank. ISR-2 In case of major mismatch in Duly filled & signed Form ISR-2 along with signature of shareholder or in case confirmation of signature of securities holder by the signature is not available with Banker Company SH-13 For furnishing Nomination details Duly filled & signed Form SH-13 for registering Nominee along with self-attested ID proof of Nominee ISR-3 Declaration form for opting out of Duly filled & signed Form ISR-3 Nomination SH-14 Cancellation or Variation in Duly filled & signed Form SH-14 Nomination The aforesaid Forms can also be downloaded from the Company’s website at https://www.panaceabiotec.com/en/section/information-repository/other-important-information https://www.panaceabiotec.com/en/investor-links/other-important-information or RTA’s website at https://www.skylinerta.com/investor-charter.php. In case of any queries or need any assistance in this regard, please contact: Panacea Biotec Limited Skyline Financial Services Private Limited Corporate Office: B-1 Extn./A-27, Mohan Co- Unit: Panacea Biotec Limited Operative, Industrial Estate, Mathura Road, D-153A, 1st Floor, Okhla Industrial Area, New Delhi – 110044 Phase-I, New Delhi-110020 Email: companysec@panaceabiotec.com Email: kyc@skylinerta.com Phone No. +91-11-41679000 Extn. - 2073 Phone No. +91-11-40450193-97 Conversion into Dematerialised Mode The Shareholders holding shares in physical form are requested to note that the Company’s securities are being traded only in dematerialised form and accordingly every physical shareholder is hereby requested to convert their holdings into dematerialised form and avail the benefits of dealing in shares in demat form. The shareholders may contact the RTA / Company for assistance in converting their holding to demat form. Thanking you, Yours Sincerely, for Panacea Biotec Limited Sd/- Authorised Signatory